Dr. Nathan Clendenen, MD MS
Claim this profileUniversity of Colorado Hospital
Affiliated Hospitals
University Of Colorado Hospital
Clinical Trials Nathan Clendenen, MD MS is currently running
Autologous Blood Transfusion
for Postoperative Hemorrhage
Autologous blood transfused at the end of cardiopulmonary bypass will reduce total blood loss 24 hours after surgery and improve mitochondrial oxygen delivery measured by plasma succinate levels. The study design is a prospective randomized interventional trial of transfusion of fresh autologous whole blood versus standard of care expectant management of bleeding during elective cardiac surgery.
Recruiting
1 award
N/A
4 criteria
Pulsatile Blood Flow
for Reducing Acute Kidney Injury
The objective is to determine the effectiveness of pulsatile flow during cardiopulmonary bypass to reduce the incidence of acute kidney injury after cardiac surgery. Investigators will also evaluate the safety and impact of pulsatile flow on clinical outcomes compared to non-pulsatile flow during cardiopulmonary bypass.
Recruiting
1 award
N/A
More about Nathan Clendenen, MD MS
Clinical Trial Related
4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Nathan Clendenen, MD MS has experience with
- Non-pulsatile Blood Flow
- Pulsatile Blood Flow
- Fresh Autologous Whole Blood
- Standard Of Care Expectant Management Of Bleeding
- Cardiopulmonary Bypass
Breakdown of trials Nathan Clendenen, MD MS has run
Acute Kidney Injury
Thrombocytopenia
Neonatal Hemolysis
Low Platelet Count
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nathan Clendenen, MD MS specialize in?
Nathan Clendenen, MD MS focuses on Acute Kidney Injury and Thrombocytopenia. In particular, much of their work with Acute Kidney Injury has involved treating patients, or patients who are undergoing treatment.
Is Nathan Clendenen, MD MS currently recruiting for clinical trials?
Yes, Nathan Clendenen, MD MS is currently recruiting for 2 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Nathan Clendenen, MD MS has studied deeply?
Yes, Nathan Clendenen, MD MS has studied treatments such as Non-pulsatile blood flow, Pulsatile blood flow, Fresh Autologous whole Blood.
What is the best way to schedule an appointment with Nathan Clendenen, MD MS?
Apply for one of the trials that Nathan Clendenen, MD MS is conducting.
What is the office address of Nathan Clendenen, MD MS?
The office of Nathan Clendenen, MD MS is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.